Cargando…
Market Access Advancements and Challenges in “Drug-Companion Diagnostic Test” Co-Development in Europe
The pharma ecosphere is witnessing a measured transformation from the one-size-fits-all or blockbuster model of drugs to more informed and tailored personalized treatments that facilitate higher safety and efficacy for a relevant sub-population. However, with several breakthroughs still in a nascent...
Autores principales: | Akhmetov, Ildar, Ramaswamy, Rakshambikai, Akhmetov, Illias, Thimmaraju, Phani Kishore |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4493497/ https://www.ncbi.nlm.nih.gov/pubmed/26075972 http://dx.doi.org/10.3390/jpm5020213 |
Ejemplares similares
-
Assessing value of innovative molecular diagnostic tests in the concept of predictive, preventive, and personalized medicine
por: Akhmetov, Ildar, et al.
Publicado: (2015) -
Pharmaceutical market access in emerging markets: concepts, components, and future
por: Kumar, Anuj, et al.
Publicado: (2014) -
Innovative payer engagement strategies: will the convergence lead to better value creation in personalized medicine?
por: Akhmetov, Ildar, et al.
Publicado: (2017) -
DFT and ONIOM Simulation of 1,3-Butadiene Polymerization Catalyzed by Neodymium-Based Ziegler–Natta System
por: Masliy, Alexey N., et al.
Publicado: (2023) -
Vortex rings
por: Akhmetov, D G
Publicado: (2009)